BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26947525)

  • 21. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis.
    Luan L; Han S; Wang H; Liu X
    Int Immunopharmacol; 2015 Dec; 29(2):278-284. PubMed ID: 26585971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriasis: Past, Present, and Future.
    Billi AC; Gudjonsson JE; Voorhees JJ
    J Invest Dermatol; 2019 Nov; 139(11):e133-e142. PubMed ID: 31648690
    [No Abstract]   [Full Text] [Related]  

  • 23. Pulmonary sarcoidosis: diagnostic and treatment update.
    Fahim A; Mann JS
    Expert Rev Respir Med; 2014 Aug; 8(4):493-501. PubMed ID: 24832794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrence of pulmonary sarcoidosis].
    Puścińska E; Zych D; Pawlicka L; Zieliński J
    Pneumonol Alergol Pol; 1995; 63(7-8):389-92. PubMed ID: 8520555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary sarcoidosis and autoimmune hemolytic anemia: possible common immune pathogenesis.
    Ghaddar RK; Muzaffar TH
    Arch Iran Med; 2011 Mar; 14(2):146-8. PubMed ID: 21361724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of psoriasis.
    Mahajan R; Handa S
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S1-9. PubMed ID: 23974689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression.
    Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA
    Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis.
    Choe YB; Hwang YJ; Hahn HJ; Jung JW; Jung HJ; Lee YW; Ahn KJ; Youn JI
    Br J Dermatol; 2012 Oct; 167(4):762-7. PubMed ID: 22564054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.
    Eysteinsdóttir JH; Sigurgeirsson B; Ólafsson JH; Fridriksson T; Agnarsson BA; Davíðsson S; Valdimarsson H; Lúðvíksson BR
    Scand J Immunol; 2013 Dec; 78(6):529-37. PubMed ID: 24111693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway.
    Balato A; Schiattarella M; Di Caprio R; Lembo S; Mattii M; Balato N; Ayala F
    J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1016-24. PubMed ID: 24033358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
    Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
    JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sarcoidosis and transverse myelitis].
    Cano A; Martínez X; Barrufet P; Fossas P
    Med Clin (Barc); 1999 Mar; 112(11):438-9. PubMed ID: 10231780
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin.
    Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of methotrexate in patients with sarcoidosis.
    Kiltz U; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S183-5. PubMed ID: 21044457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle.
    Farkas A; Kemény L
    Int Immunopharmacol; 2012 Jun; 13(2):215-8. PubMed ID: 22522054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudo-tumoural sarcoidosis.
    Thilmany S; Saelens C; Lhommel R; Lambert M
    Acta Clin Belg; 2013; 68(2):150-1. PubMed ID: 23967730
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeting the Th17 pathway in psoriasis.
    Elloso MM; Gomez-Angelats M; Fourie AM
    J Leukoc Biol; 2012 Dec; 92(6):1187-97. PubMed ID: 22962689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pulmonary sarcoidosis].
    Borisova NK; Daurov BI
    Vestn Rentgenol Radiol; 1991; (3):5-11. PubMed ID: 1364797
    [No Abstract]   [Full Text] [Related]  

  • 39. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris.
    Niu X; Cao W; Ma H; Feng J; Li X; Zhang X
    J Dermatol; 2012 Nov; 39(11):916-21. PubMed ID: 22913391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis.
    Ten Berge B; Paats MS; Bergen IM; van den Blink B; Hoogsteden HC; Lambrecht BN; Hendriks RW; Kleinjan A
    Rheumatology (Oxford); 2012 Jan; 51(1):37-46. PubMed ID: 22075064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.